Genetic analyses of viral samples from 74 laboratory confirmed measles cases occurring in Taiwan during 1992-2008 identified six viral genotypes D3, D5, D9, G2, H1 and H2. The most frequently detected genotype, H1, was associated with outbreaks in 1994 and 2002, and was the likely indigenous genotype in 1992. In response to the outbreaks, two catch-up campaigns were launched and a routine second dose of measles, mumps, and rubella vaccine at entry to elementary school was introduced. The vaccination campaigns successfully reduced the number of measles cases in Taiwan, and many of the more recent cases can be traced to importations, primarily from other Asian countries. A number of measles genotypes which were associated with outbreaks in other Asian countries were detected among the more recent cases. The more recent genotype H1 viruses had sequences that were identical to those currently circulating in China or associated with international importation of virus.
Measles is a contagious human disease caused by measles virus (MeV). Symptoms include high fever, conjunctivitis, coryza, cough, the appearance of Koplik spots on the buccal mucosa and a maculopapular rash. Vaccination programs have dramatically reduced the incidence of measles on a global scale [
As part of laboratory-based surveillance for measles, genetic characterization of circulating wild-type viruses provides an important tool for mapping transmission routes, documenting the elimination of endemic strains, and distinguishing vaccine reactions from wild-type infections [
Live attenuated measles vaccine was first introduced to Taiwan in 1968, but no mass vaccination policy was established. From 1978 to 1987, the vaccine was provided to infants at both 9 and 15 months of age. In early 1988, vaccination was scheduled for 12-months of age, but a two-dose schedule (9 months and 15 months) was initiated later in the year because an outbreak occurred, and this policy continued until 1991. In 1992, one dose of measles vaccine was given at 9-months and a second dose of measles, mumps, and rubella vaccine (MMR) was administered at 15-months. Two catch-up campaigns were implemented to improve coverage rates in response to small outbreaks. From 1992 to 1994, the campaign targeted junior high school through preschool children (birth cohort 1976/09 to 1990/09), while the campaign of 2001 to 2004 was aimed at elementary school students (birth cohort 1990/09 to 1994/09). The current two-dose MMR program for 12-15 month old infants and first graders (6 years old) was implemented in 2006 [
In 1985, measles was listed as a reportable disease in Taiwan, but routine serologic confirmation of infection was not started until 1991. In 2000, to strengthen measles surveillance, laboratory confirmation was required for all suspected cases. Starting in 2002, clinical specimens including throat swabs, urine, and whole blood were also obtained for virological surveillance.
In this study, the viral genotypes associated with 74 confirmed cases of measles that occurred in Taiwan between 1992 and 2008 were determined.
Sixteen sequences were obtained from viral isolates and the others were obtained directly from clinical samples. Therefore, this is the first report that describes the molecular epidemiology of MeV in Taiwan.
Measles was listed as a reportable disease since 1985 and information regarding measles infections before 1985 is incomplete. From 1985 to 1992, four major measles outbreaks occurred in Taiwan (Figure
Genetic analysis was conducted on 74 measles cases (Table
Genetic characterization of measles viruses in Taiwan, 1992-2008
| Strain Designation | Age (yy/mm) | Specimen | Genotype | Accession numbera | Vaccination | Comment | |
|---|---|---|---|---|---|---|---|
| MVs/Taiwan/18.92/1 | 00/10 | serum | H1 | Unknown | |||
| MVs/Taiwan/18.92/2 | 10/02 | serum | D5 | Unknown | |||
| MVs/Keelung.TWN/18.92/3 | 04/02 | serum | H1 | Unknown | |||
| MVs/Taiwan/19.92 | 13/06 | serum | D3 | Unknown | |||
| MVs/Taiwan/22.92/1 | 01/09 | serum | H1 | Unknown | |||
| MVs/Taiwan/22.92/2 | unknown | serum | H1 | Unknown | |||
| MVs/Taipei.TWN/11.93 | 02/10 | serum | H1 | Unknown | |||
| MVs/Keelung.TWN/23.93 | 01/09 | serum | H1 | Unknown | |||
| MVi/Taoyuan.TWN/21.94 | 03/10 | throat swab | H1 | Unknown | 1994 Taoyuan measles outbreak | ||
| MVi/Taoyuan.TWN/22.94 | 05/10 | whole blood | H1 | Unknown | 1994 Taoyuan measles outbreak | ||
| MVi/Taoyuan.TWN/24.94/1 | 02/10 | throat swab | H1 | Unknown | 1994 Taoyuan measles outbreak | ||
| MVi/Taoyuan.TWN/24.94/2 | 03/08 | whole blood | H2 | Unknown | 1994 Taoyuan measles outbreak | ||
| MVi/Taoyuan.TWN/24.94/3 | 03/10 | throat swab | H1 | Unknown | 1994 Taoyuan measles outbreak | ||
| MVs/Taichung.TWN/21.97/1 | 01/00 | serum | G2 | Unknown | |||
| MVs/Taichung.TWN/21.97/2 | 00/05 | serum | G2 | No | |||
| MVs/Taichung.TWN/23.97 | 10/08 | serum | G2 | Unknown | |||
| MVs/Taipei.TWN/36.97 | 01/02 | serum | H1 | Unknown | |||
| MVs/Chiayi.TWN/13.98 | 01/07 | serum | H2 | Unknown | Nosocomial | ||
| MVs/Chiayi.TWN/16.98 | 00/10 | serum | H2 | Yes | Nosocomial | ||
| MVs/Taipei.TWN/11.00 | 00/10 | serum | D3 | No | |||
| MVs/Hualian.TWN/12.00 | 00/11 | serum | D5 | No | |||
| MVs/Taitung.TWN/21.00 | 27/07 | serum | H1 | Unknown | |||
| MVs/Taipei.TWN/07.01 | 28/09 | serum | H1 | Unknown | Imported from China | ||
| MVs/Hsinchu.TWN/11.01/1 | 00/09 | serum | H1 | No | |||
| MVs/Hsinchu.TWN/11.01/2 | 00/08 | serum | H1 | No | |||
| MVs/Taipei.TWN/16.01 | 22/00 | serum | H1 | Unknown | |||
| MVs/Taoyuan.TWN/29.01 | 00/10 | serum | H1 | No | Imported from China | ||
| MVs/Taoyuan.TWN/45.01 | 00/09 | serum | H1 | No | Imported from China | ||
| MVs/Taichung.TWN/10.02 | 01/00 | serum | D3 | No | Imported from Philippines | ||
| MVs/Taipei.TWN/14.02 | 09/10 | serum | H1 | Yes | |||
| MVs/Kaohsiung.TWN/16.02 | 29/04 | serum | D5 | No | |||
| MVs/Taipei.TWN/26.02 | 00/07 | urine | H1 | No | Imported from China | ||
| MVs/Taipei.TWN/27.02 | 00/10 | throat swab | H1 | No | Imported from China | ||
| MVs/Pingtung.TWN/33.02 | 00/06 | urine | H1 | No | Imported from China | ||
| MVs/Miaoli.TWN/34.02 | 27/04 | urine | H1 | Yes | |||
| MVs/Taichung.TWN/36.02/1 | 00/07 | throat swab | H1 | No | |||
| MVs/Taipei.TWN/36.02/2 | 26/01 | urine | H1 | Yes | |||
| MVs/Taichung.TWN/38.02 | 14/10 | urine | H1 | Yes | Taichung outbreak, school clustering | ||
| MVs/Taichung.TWN/39.02/1 | 09/11 | urine | H1 | No | Taichung outbreak, school clustering | ||
| MVs/Hsinchu.TWN/39.02/2 | 00/01 | serum | H1 | No | |||
| MVi/Taichung.TWN/40.02/1 | 13/02 | urine | H1 | Yes | Taichung outbreak, school clustering | ||
| MVi/Taichung.TWN/40.02/2 | 09/11 | urine | H1 | Yes | Taichung outbreak, school clustering | ||
| MVi/Taichung.TWN/40.02/3 | 13/03 | whole blood | H1 | Yes | Taichung outbreak, school clustering | ||
| MVs/Hsinchu.TWN/40.02/4 | 29/00 | serum | H1 | Unknown | |||
| MVs/Taichung.TWN/41.02 | 13/11 | urine | H1 | Yes | Taichung outbreak, school clustering | ||
| MVs/Hualian.TWN/18.03/1 | 00/10 | serum | D3 | No | Philippines native | ||
| MVi/Hualian.TWN/18.03/2 | 00/10 | whole blood | D3 | No | Philippines native | ||
| MVi/Taoyuan.TWN/20.03 | 00/11 | throat swab | H1 | No | Imported from China | ||
| MVs/Taichung.TWN/45.03 | 28/10 | urine | D5 | Yes | Imported from Thailand | ||
| MVs/Yilan.TWN/48.03 | 25/01 | throat swab/urine | D9 | Unknown | |||
| MVi/Taipei.TWN/09.05 | 01/02 | throat swab | H1 | No | Household | ||
| MVs/Taipei.TWN/10.05 | 02/00 | urine | H1 | No | Household | ||
| MVs/Taipei.TWN/46.05 | 40/04 | urine | D5 | No | German native | ||
| MVs/Taipei.TWN/17.06 | 00/10 | throat swab/urine | H1 | No | Imported from China | ||
| MVs/Tainan.TWN/21.06 | 00/10 | urine | H1 | No | Imported from China | ||
| MVs/Taipei.TWN/39.06 | 25/08 | throat swab/urine | H1 | No | Imported from China | ||
| MVs/Tainan.TWN/23/07/1 | 30/09 | throat swab/urine | D5 | No | Imported from Japan | ||
| MVi/Taipei.TWN/23.07/2 | 26/05 | throat swab/urine | D5 | Unknown | Imported from Japan | ||
| MVi/Taipei.TWN/30.07 | 00/10 | urine | H1 | No | Imported from China | ||
| MVs/Tainan.TWN/31.07/1 | 00/07 | urine | H1 | No | Imported from China | ||
| MVs/Tainan.TWN/33.07 | 01/02 | throat swab/urine | H1 | No | Imported from China | ||
| MVs/Taipei.TWN/34.07 | 16/05 | throat swab/urine | D5 | Unknown | Imported from Japan | ||
| MVs/Hualian.TWN/01.08 | 04/11 | throat swab | D9 | No | Imported from Philippines | ||
| MVi/Taipei.TWN/05.08 | 27/00 | urine | H1 | Unknown | Imported from China | ||
| MVs/Chayi.TWN/11.08 | 00/10 | throat swab/urine | H1 | No | Imported from China | ||
| MVs/Taipei.TWN/16.08 | 45/07 | throat swab/urine | H1 | Unknown | Imported from China | ||
| MVi/Taipei.TWN/17.08 | 32/07 | urine | D5 | Unknown | Imported from Japan | ||
| MVs/Taoyuan.TWN/29.08 | 22/11 | throat swab | H1 | Unknown | |||
| MVs/Taipei.TWN/34.08/1 | 25/04 | urine | D9 | Unknown | Imported from Thailand | ||
| MVs/Taipei.TWN/34.08/2 | 00/10 | throat swab/urine | D9 | No | Household | ||
| MVs/Kaohsiung.TWN/45.08 | 01/05 | throat swab | H1 | No | Imported from China | ||
| MVs/Kaohsiung.TWN/47.08 | 04/05 | throat swab | H1 | No | Nosocomial | ||
| MVs/Kaohsiung.TWN/52.08 | 00/09 | throat swab/urine | H1 | No | Nosocomial | ||
| MVi/Kaohsiung.TWN/53.08 | 39/11 | urine | H1 | No | Nosocomial | ||
a Indicates N gene Genbank accession number
Genotype D3 was detected in five cases, and three of these (1 in 2002, 2 in 2003) were travelers from the Philippines (Figure
Genotype D5 was detected in nine cases in Taiwan. Genotype D5 has been reported to be circulating in Thailand and had been associated with cases in Japan and imported cases in the USA [
The genotype D9 sequence from 2003 was obtained from a 25-year-old woman who had traveled to Japan for 10 days before onset of clinicalsymptoms. Three other D9 sequences were obtained in 2008, one was from 4 year old girl who traveled to the Philippines 13 days before rash appeared. The other two cases from 2008 were from the same household including a 25 year old man who had traveled to Thailand 10 days before rash onset and then transmitted virus to his 10 months old niece. Genotype D9 was initially detected in East Timor and Java, Indonesia [
Genotype G2 was first identified in 1997 in Indonesia and Malaysia [
Genotype H1 was detected in 50 of the 74 samples from cases occurring during 1992-2008. In 1992, genotype H1 sequences belonged to two lineages within what has been described as genotype H1, cluster 1 [
There were 26 measles cases confirmed by serology in 2002, and 10 cases were from a school outbreak that occurred from September to October. There were 17 cases with sequence information and 15 of the H1 sequences belonged to 3 different lineages. Of those, 3 were imported from China (MVs/Taipei.TWN/26.02, MVs/Taipei.TWN/27.02, and MVs/Pingtung.TWN/33.02). Nine of the H1 isolates associated with the 2002 outbreak (six of these were either household or school clustering) had identical sequences and formed a separate lineage (Table
The genotype H1 sequence detected in 2003 was from an eleven months old infant returning from a visit to China. The two cases with genotype H1 in 2005 were in the same family and there was no history of travel. The six genotype H1 sequences detected in 2006-2007 were all imported from China (Table
Among the 50 H1 sequences characterized, forty-five cases were clustered with the reference strain for genotype H1 (Figure
Only three cases were confirmed to be associated with genotype H2, one was in 1994 from the Taoyuan outbreak and the other two were from an outbreak in a hospital in 1998. Although no information regarding the source of these cases was available, these are more closely related to the isolates from Vietnam [
Historically, clade H of MeV was associated with Asian countries, with genotype H1 being prevalent in China [
This report contains the first analysis of the genetic characteristics of MeVs circulating in Taiwan over the seventeen year period from 1992 to 2008. In Taiwan, measles vaccination started in 1978, but epidemiologic information was not available until 1991. Laboratory-based surveillance was initiated in 1991, but routine virological sampling did not occur until 2002. Before 2000, only serum samples were collected and the percentage of sampling from all reported cases was variable (range: 52% to 85%). The low sampling rate from 1995, 1996, and 1999, of 59.5%, 59.6%, and 52.2% respectively, could have contributed to the absence of confirmed measles cases for those years.
Even though virological surveillance was not conducted in Taiwan before 1992, the data presented here suggest that MeV genotype H1, the most frequently detected genotype in the study, represented the indigenous genotype in Taiwan. Genotype H1 viruses were detected almost every year beginning in 1992 with the exception of 1995, 1996, 1998, 1999, and 2004 (Table
Recent virological surveillance has documented the spread of MeV in the Western Pacific Region. A large measles outbreak that occurred in Korea in 2000 was caused by genotype H1 viruses [
In the dendrogram derived from the N gene sequences (Figure
The diversity of genotypes and the low number of cases in Taiwan is similar to what has been described in other countries that are in elimination phases of measles control [
This study reported the first analysis of the genetic characteristics of MeVs circulating in Taiwan over the seventeen year period from 1992 to 2008. Genetic analyses of viral samples from laboratory confirmed measles cases identified six viral genotypes D3, D5, D9, G2, H1 and H2. Genotype H1 remains the most frequently encountered MeV transmitted among Asian countries. Recent measles cases were epidemiologically linked to the importation from foreign countries. These results highlight the importance of integration of immunization programs, disease surveillance systems, and laboratory diagnosis.
Specimens including throat swabs, urine, whole blood, or serum were collected from suspected cases and tested in the laboratory at the Taiwan CDC. During the period of 1992-2008, various specimens from 896 suspected patients were collected for laboratory tests. Specimens were processed with RT-PCR amplification from a total of 174 patients, including 42 with only one serum collected at the acute phase and tested negative for measles IgM and IgG, the other 132 cases were serologically confirmed with positive measles IgM. Finally, 74 confirmed measles cases, including 16 virus isolates, were sequenced and used for genetic characterization. Here, a confirmed case is defined serologically either by a positive IgM, or a significant rise (4× or higher) of IgG titer between acute and convalescence phase, or a positive RT-PCR result from various clinical samples (serum, throat swab or urine). Any confirmed case that has travel history abroad 7-23 days before onset of rash is classified as an imported case [
Serum specimens were tested for measles IgM and IgG antibodies using Enzygnost Anti-Marsen-Virus/IgM, Enzygnost Anti-Marsen-Virus/IgG (Dade Behring, Marburg, Germany) following the manufacturer's instructions.
Clinical specimens including throat swab, urine sediments and lymphocytes were inoculated onto B95a cells, a marmoset B lymphoblastoid cell line transformed by Epstein-Barr virus [
RNA was extracted from infected cells or directly from clinical specimens by using the Viral RNA mini kit (Qiagen Inc., Chatsworth, CA) following the manufacturer's instructions. To obtain the sequence of the 450 nt region of the measles N gene that is required for genotyping, RT-PCR was performed by using a one-step RT-PCR kit (Qiagen) with reverse primer MV64 (nt 1719-1739, 5'-TATAACAATGATGGAGGGTAG-3') and forward primer MV59 (nt 866-889., 5'-GATATGTGACATTGATACATATAT-3'). Primer concentration was 0.4 μM each. The PCR cycling conditions were reverse transcription at 50°C for 30 min, initial PCR activation step by 95°C for 15 min, followed by 35 cycles of 30 s at 94°C, 30 s at 51°C and 1 min at 72°C, with a final extension for 5 min at 72°C. A nested PCR was then performed on the resulting PCR product of 873 bps using HotStartTaq Master Mix Kit (Qiagen) with primers MV60 and MV63 (0.2 μM each) as described elsewhere [
MeV: measles virus; MMR: measles, mumps, and rubella; RT-PCR: reverse transcription-polymerase chain reaction; CPE: cytopathic effect; N: Nucleoprotein.
The authors declare that they have no competing interests.
WYC carried out most of the studies and drafted the manuscript. LL participated parts of the studies and writing. PAR provided consultation and editing of the manuscript. DCY provided consultation and preparation of the final report. All authors read and approved the final manuscript.
We wish to thank Ms. Hsiao-Chi Wang who assisted in the serologic tests, and Mr. Yu-lin Ho who helped in processing of specimens. Thanks to Drs. Ming-Tsan Liu, Jyh-Yuan Yang, and Ho-Sheng Wu for their support and guidance. This study was supported in part by research grant from CDC Taiwan.